Inkstone Feibo Acquisition, a biotech and green tech SPAC, registered to offer 6 million units at $10 each. A unit consists of one share and half a warrant.
The SPAC said it will focus on opportunities in biotechnology and green technology industries with an emphasize on Environmental, Social and Governance (“ESG”) practices in the United States and Taiwan. Inkstone Feibo said it would not do a deal with any company based in or having a majority of operations in China, Hong Kong or Macau. All of the management team are located outside of China.
CEO and Chairman I-Fa Chang in 2012 founded Inkstone Capital Co., Ltd., a technology-focused investment advisory firm serving clients in Mainland China, Hong Kong and Taiwan.
Tiger Brokers is sole book-running manager.
Inkstone Feibo has applied for a Nasdaq listing, but has notr yet selected a ticker symbol. Read more.
